Browsing Tag
FDA
1 post
US Advisory Committee Moves to Ease Curbs on Popular but Unverified Peptides
A US FDA advisory panel has voted to lower barriers for specialized pharmacies to produce controversial peptides like BPC-157 and KPV, despite significant concerns over a lack of human safety data.
July 24, 2026